Home  >  Products  >  UBE2V1 (ubiquitin-conjugating enzyme E2 variant 1 ) Blocking Peptide (the N terminal of UBE2V1)(100ug)
UBE2V1 (ubiquitin-conjugating enzyme E2 variant 1 ) Blocking Peptide (the N terminal of UBE2V1)(100ug)

UBE2V1 (ubiquitin-conjugating enzyme E2 variant 1 ) Blocking Peptide (the N terminal of UBE2V1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-UBE2V1 Antibody (ARP61717_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP61717
Size: 100ug
Weight: 19kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: Ubiquitin-conjugating E2 enzyme variant proteins constitute a distinct subfamily within the E2 protein family. They have sequence similarity to other ubiquitin-conjugating enzymes but lack the conserved cysteine residue that is critical for the catalytic activity of E2s. The protein encoded by this gene is located in the nucleus and can cause transcriptional activation of the human FOS proto-oncogene. It is thought to be involved in the control of differentiation by altering cell cycle behavior. Multiple alternatively spliced transcripts encoding different isoforms have been described for this gene. A pseudogene has been identified which is also located on chromosome 20. Co-transcription of this gene and the neighboring upstream gene generates a rare transcript (Kua-UEV), which encodes a fusion protein comprised of sequence sharing identity with each individual gene product.
Alternative names: CIR1; CROC-1; CROC1; UBE2V; UEV-1; UEV1; UEV1A
See Full Product Listings >